140 related articles for article (PubMed ID: 28872660)
1. Fabricating PLGA microparticles with high loads of the small molecule antioxidant N-acetylcysteine that rescue oligodendrocyte progenitor cells from oxidative stress.
Murphy NP; Lampe KJ
Biotechnol Bioeng; 2018 Jan; 115(1):246-256. PubMed ID: 28872660
[TBL] [Abstract][Full Text] [Related]
2. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
4. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
6. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
Takami T; Murakami Y
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine alleviated paraquat-induced mitochondrial fragmentation and autophagy in primary murine neural progenitor cells.
Xiong G; Zhao L; Yan M; Wang X; Zhou Z; Chang X
J Appl Toxicol; 2019 Nov; 39(11):1557-1567. PubMed ID: 31368586
[TBL] [Abstract][Full Text] [Related]
8. Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity.
Ourique AF; Chaves Pdos S; Souto GD; Pohlmann AR; Guterres SS; Beck RC
Eur J Pharm Sci; 2014 Dec; 65():174-82. PubMed ID: 25263567
[TBL] [Abstract][Full Text] [Related]
9. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.
Liu J; Zhang SM; Chen PP; Cheng L; Zhou W; Tang WX; Chen ZW; Ke CM
J Mater Sci Mater Med; 2007 Nov; 18(11):2205-10. PubMed ID: 17668296
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with α-tocopherol-ascorbic acid surfactant.
Astete CE; Dolliver D; Whaley M; Khachatryan L; Sabliov CM
ACS Nano; 2011 Dec; 5(12):9313-25. PubMed ID: 22017172
[TBL] [Abstract][Full Text] [Related]
12. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
Lee YH; Mei F; Bai MY; Zhao S; Chen DR
J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
[TBL] [Abstract][Full Text] [Related]
14. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
[TBL] [Abstract][Full Text] [Related]
15. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional PLGA particles containing poly(l-glutamic acid)-capped silver nanoparticles and ascorbic acid with simultaneous antioxidative and prolonged antimicrobial activity.
Stevanović M; Bračko I; Milenković M; Filipović N; Nunić J; Filipič M; Uskoković DP
Acta Biomater; 2014 Jan; 10(1):151-62. PubMed ID: 23988864
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury.
Sun Y; Pu LY; Lu L; Wang XH; Zhang F; Rao JH
World J Gastroenterol; 2014 Nov; 20(41):15289-98. PubMed ID: 25386077
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells.
Wu W; Abraham L; Ogony J; Matthews R; Goldstein G; Ercal N
Life Sci; 2008 May; 82(21-22):1122-30. PubMed ID: 18448127
[TBL] [Abstract][Full Text] [Related]
19. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
20. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]